BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21920697)

  • 21. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal changes in emergency department triage of patients with acute myocardial infarction and the effect on outcomes.
    Atzema CL; Schull MJ; Austin PC; Tu JV
    Am Heart J; 2011 Sep; 162(3):451-9. PubMed ID: 21884860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.
    Björck L; Capewell S; Bennett K; Lappas G; Rosengren A
    J Intern Med; 2011 Apr; 269(4):452-67. PubMed ID: 21205025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes.
    Yan RT; Yan AT; Tan M; McGuire DK; Leiter L; Fitchett DH; Lauzon C; Lai K; Chow CM; Langer A; Goodman SG;
    Am Heart J; 2006 Oct; 152(4):676-83. PubMed ID: 16996832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCORT/CCS quality indicators for congestive heart failure care.
    Lee DS; Tran C; Flintoft V; Grant FC; Liu PP; Tu JV;
    Can J Cardiol; 2003 Mar; 19(4):357-64. PubMed ID: 12704479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification after successful coronary revascularization.
    Goto M; Kohsaka S; Aoki N; Lee VV; Elayda MA; Wilson JM
    Cardiovasc Revasc Med; 2008; 9(3):132-9. PubMed ID: 18606375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005.
    Wijeysundera HC; Machado M; Farahati F; Wang X; Witteman W; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Krahn M; Capewell S
    JAMA; 2010 May; 303(18):1841-7. PubMed ID: 20460623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambient air pollutants and risk of fatal coronary heart disease among kidney transplant recipients.
    Spencer-Hwang R; Knutsen SF; Soret S; Ghamsary M; Beeson WL; Oda K; Shavlik D; Jaipaul N
    Am J Kidney Dis; 2011 Oct; 58(4):608-16. PubMed ID: 21778006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent impact of gout on mortality and risk for coronary heart disease.
    Choi HK; Curhan G
    Circulation; 2007 Aug; 116(8):894-900. PubMed ID: 17698728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    Eur J Public Health; 2007 Apr; 17(2):193-8. PubMed ID: 16798782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006.
    Kabir Z; Perry IJ; Critchley J; O'Flaherty M; Capewell S; Bennett K
    Int J Cardiol; 2013 Oct; 168(3):2462-7. PubMed ID: 23541608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-Canadian cardiovascular data definitions and quality indicators: a status update.
    Johnstone DE; Buller CE;
    Can J Cardiol; 2012; 28(5):599-601. PubMed ID: 22552173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential reductions in United States coronary heart disease mortality by treating more patients.
    Capewell S; O'Flaherty M; Ford ES; Critchley JA
    Am J Cardiol; 2009 Jun; 103(12):1703-9. PubMed ID: 19539079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing the impact of cardiological treatments. How best to reduce deaths.
    Capewell S; Pell JP; Morrison C; McMurray J
    Eur Heart J; 1999 Oct; 20(19):1386-92. PubMed ID: 10487799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease.
    Gemmell I; Heller RF; McElduff P; Payne K; Butler G; Edwards R; Roland M; Durrington P
    J Epidemiol Community Health; 2005 Dec; 59(12):1041-6. PubMed ID: 16286491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.